FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1974117002> ?p ?o ?g. }

• W1974117002 abstract "Only one-third of elderly (>60 years) AML and MDS-RAEB2 patients may receive intensive chemotherapy treatment alternatives that are limited in this patient group due to the potential of severe toxicity. Previous studies have shown that azacitidine and low dose cytarabine treatments may be a beneficial treatment option for these patients. In this study, we aimed to good results with low toxicity in elderly patients. We retrospectively analyzed the AML and MDS-RAEB2 patients who received azacitidine monotherapy and azacitidine and LDL-ara-c combination therapy for a comparison of their response to therapy, survival rates, and toxicity rates and for determining the factors that could affect their overall survival. A total of 27 patients who were diagnosed with de novo AML and MDS-RAEB2 and who received at least four cycles of chemotherapy were included in the study, and the data were evaluated retrospectively. When monotherapy and combination therapy groups were compared, the pretreatment bone marrow blast count was observed to be greater in the combination therapy group. A statistically significant difference was not detected between the groups regarding the response to therapy ratios (p = 0.161) (42.9 and 57.1 %, respectively). No difference was detected between the groups regarding therapy-related toxicity. Infections were the most common complication. Progression-free survival was 30.3 % for the azacitidine monotherapy group and 66.7 % for the combination (azacitidine + LD-ara-c) group. The factors influencing the overall survival rate were determined based on the response to the first-line therapies, more than a grade 2 infection, fever, and relapse in a multi-variance analysis. The combination therapy may be a well-tolerated treatment option for the elderly, vulnerable AML patients whose blast count is high in response to therapy rates, overall survival rates, and toxicities are not different, although the pre-treatment bone marrow blast count was greater in the combination therapy groups compared with the monotherapy group." @default.
• W1974117002 created "2016-06-24" @default.
• W1974117002 creator A5035163221 @default.
• W1974117002 creator A5078148420 @default.
• W1974117002 date "2015-02-01" @default.
• W1974117002 modified "2023-10-17" @default.
• W1974117002 title "Low Dose Cytosine Arabinoside and Azacitidine Combination in Elderly Patients with Acute Myeloid Leukemia and Refractory Anemia with Excess Blasts (MDS-RAEB2)" @default.
• W1974117002 cites W1572539757 @default.
• W1974117002 cites W1645524462 @default.
• W1974117002 cites W1965658643 @default.
• W1974117002 cites W1990814650 @default.
• W1974117002 cites W2003763899 @default.
• W1974117002 cites W2015776863 @default.
• W1974117002 cites W2029595590 @default.
• W1974117002 cites W2039238951 @default.
• W1974117002 cites W2048267487 @default.
• W1974117002 cites W2067934287 @default.
• W1974117002 cites W2068556430 @default.
• W1974117002 cites W2082837995 @default.
• W1974117002 cites W2095182124 @default.
• W1974117002 cites W2099212333 @default.
• W1974117002 cites W2107398329 @default.
• W1974117002 cites W2110893339 @default.
• W1974117002 cites W2121603250 @default.
• W1974117002 cites W2126644820 @default.
• W1974117002 cites W2129357329 @default.
• W1974117002 cites W2137374045 @default.
• W1974117002 cites W2161355389 @default.
• W1974117002 cites W2147083172 @default.
• W1974117002 doi "https://doi.org/10.1007/s12288-015-0509-2" @default.
• W1974117002 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4733667" @default.
• W1974117002 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26855506" @default.
• W1974117002 hasPublicationYear "2015" @default.
• W1974117002 type Work @default.
• W1974117002 sameAs 1974117002 @default.
• W1974117002 citedByCount "0" @default.
• W1974117002 crossrefType "journal-article" @default.
• W1974117002 hasAuthorship W1974117002A5035163221 @default.
• W1974117002 hasAuthorship W1974117002A5078148420 @default.
• W1974117002 hasBestOaLocation W19741170022 @default.
• W1974117002 hasConcept C104317684 @default.
• W1974117002 hasConcept C121332964 @default.
• W1974117002 hasConcept C126322002 @default.
• W1974117002 hasConcept C142424586 @default.
• W1974117002 hasConcept C143998085 @default.
• W1974117002 hasConcept C150194340 @default.
• W1974117002 hasConcept C185592680 @default.
• W1974117002 hasConcept C190727270 @default.
• W1974117002 hasConcept C194409129 @default.
• W1974117002 hasConcept C2776239401 @default.
• W1974117002 hasConcept C2776694085 @default.
• W1974117002 hasConcept C2776999253 @default.
• W1974117002 hasConcept C2778041864 @default.
• W1974117002 hasConcept C2778461978 @default.
• W1974117002 hasConcept C2778729363 @default.
• W1974117002 hasConcept C29730261 @default.
• W1974117002 hasConcept C55493867 @default.
• W1974117002 hasConcept C71924100 @default.
• W1974117002 hasConcept C87355193 @default.
• W1974117002 hasConcept C90924648 @default.
• W1974117002 hasConceptScore W1974117002C104317684 @default.
• W1974117002 hasConceptScore W1974117002C121332964 @default.
• W1974117002 hasConceptScore W1974117002C126322002 @default.
• W1974117002 hasConceptScore W1974117002C142424586 @default.
• W1974117002 hasConceptScore W1974117002C143998085 @default.
• W1974117002 hasConceptScore W1974117002C150194340 @default.
• W1974117002 hasConceptScore W1974117002C185592680 @default.
• W1974117002 hasConceptScore W1974117002C190727270 @default.
• W1974117002 hasConceptScore W1974117002C194409129 @default.
• W1974117002 hasConceptScore W1974117002C2776239401 @default.
• W1974117002 hasConceptScore W1974117002C2776694085 @default.
• W1974117002 hasConceptScore W1974117002C2776999253 @default.
• W1974117002 hasConceptScore W1974117002C2778041864 @default.
• W1974117002 hasConceptScore W1974117002C2778461978 @default.
• W1974117002 hasConceptScore W1974117002C2778729363 @default.
• W1974117002 hasConceptScore W1974117002C29730261 @default.
• W1974117002 hasConceptScore W1974117002C55493867 @default.
• W1974117002 hasConceptScore W1974117002C71924100 @default.
• W1974117002 hasConceptScore W1974117002C87355193 @default.
• W1974117002 hasConceptScore W1974117002C90924648 @default.
• W1974117002 hasLocation W19741170021 @default.
• W1974117002 hasLocation W19741170022 @default.
• W1974117002 hasLocation W19741170023 @default.
• W1974117002 hasLocation W19741170024 @default.
• W1974117002 hasOpenAccess W1974117002 @default.
• W1974117002 hasPrimaryLocation W19741170021 @default.
• W1974117002 hasRelatedWork W1974749085 @default.
• W1974117002 hasRelatedWork W1982035148 @default.
• W1974117002 hasRelatedWork W1995164843 @default.
• W1974117002 hasRelatedWork W2001839862 @default.
• W1974117002 hasRelatedWork W2031657565 @default.
• W1974117002 hasRelatedWork W2052867770 @default.
• W1974117002 hasRelatedWork W2104222465 @default.
• W1974117002 hasRelatedWork W2121603250 @default.
• W1974117002 hasRelatedWork W2330246487 @default.
• W1974117002 hasRelatedWork W2411430126 @default.
• W1974117002 hasRelatedWork W2530454957 @default.
• W1974117002 hasRelatedWork W2548477270 @default.
• W1974117002 hasRelatedWork W2588480703 @default.
• W1974117002 hasRelatedWork W2750468541 @default.

• next